LOGO
LOGO

Corporate News

NeuroPace Stock Falls 6.7% Following Public Offering Announcement

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

NeuroPace, Inc. (NPCE) is down 6.70 percent, declining $0.81 to $11.28, after announcing a public offering of 6.5 million shares at $10.00 per share, expected to raise $65 million.

NPCE is currently trading at $11.52 after opening at $10.30. The stock has moved between $10.30 and $11.50 today. Trading volume is at 1.10 million shares, significantly higher than the average of 114,016.

NeuroPace remains within its 52-week range of $5.45 to $18.15 as investors react to the dilution impact of the new share offering.

The offering is set to close on February 18, with underwriters granted a 30-day option to purchase up to an additional 975,000 shares.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.
Global Economics Weekly Update -June 15 - June 19, 2026

June 19, 2026 16:46 ET
Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.